Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBITDA Margin (2016 - 2018)

Historic EBITDA Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 326.71%.

  • Armata Pharmaceuticals' EBITDA Margin rose 121517100.0% to 326.71% in Q4 2018 from the same period last year, while for Dec 2018 it was 1015.89%, marking a year-over-year increase of 150645900.0%. This contributed to the annual value of 762.14% for FY2024, which is 29108500.0% up from last year.
  • According to the latest figures from Q4 2018, Armata Pharmaceuticals' EBITDA Margin is 326.71%, which was up 121517100.0% from 902.61% recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year EBITDA Margin high stood at 18733.01% for Q3 2014, and its period low was 53927.27% during Q4 2016.
  • Its 5-year average for EBITDA Margin is 6313.92%, with a median of 2541.18% in 2015.
  • In the last 5 years, Armata Pharmaceuticals' EBITDA Margin surged by 2000000000bps in 2014 and then crashed by -516304000bps in 2016.
  • Over the past 5 years, Armata Pharmaceuticals' EBITDA Margin (Quarter) stood at 2571.29% in 2014, then grew by 11bps to 2296.88% in 2015, then tumbled by -2248bps to 53927.27% in 2016, then skyrocketed by 78bps to 11825.0% in 2017, then soared by 103bps to 326.71% in 2018.
  • Its last three reported values are 326.71% in Q4 2018, 902.61% for Q3 2018, and 1124.56% during Q2 2018.